Evidence map›Paper›PMID 36983614›Full record

ArticleJournal of personalized medicine2023

Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy.

Shizune Onuma, Itaru Hashimoto, Hideaki Suematsu, Shinsuke Nagasawa, Kyohei Kanematsu, Toru Aoyama, Takanobu Yamada, Yasushi Rino, Takashi Ogata, Takashi Oshima

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shizune OnumaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Itaru HashimotoDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.ORCID 0000-0002-8398-1494
Hideaki SuematsuDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Shinsuke NagasawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Kyohei KanematsuDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Toru AoyamaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Takanobu YamadaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University, Yokohama 236-0004, Japan.
Takashi OgataDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
Takashi OshimaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama 241-8515, Japan.ORCID 0000-0001-5818-8649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative inflammatory and nutritional statuses have potential prognostic effects on patients with gastric cancer (GC) after curative gastrectomy. We investigated the prognostic usefulness of the preoperative neutrophil-to-lymphocyte ratio/albumin ratio (NLR/Alb) in patients with GC. Among 483 patients who underwent gastrectomy for GC, the preoperative prognostic nutritional index (PNI), NLR, and NLR/Alb were calculated using preoperative blood test data. The patients were divided into the high and low PNI, NLR, and NLR/Alb groups. The associations of preoperative PNI, NLR, and NLR/Alb with clinicopathological features, 3-year (3Y) overall survival (OS) rates, and relapse-free survival (RFS) rates after gastrectomy for GC were evaluated. The number of female individuals and the C-reactive protein levels were significantly higher in the high- compared to the low-NLR/Alb group (both

Indexed as

gastric cancerneutrophil-to-lymphocyte ratio/albumin ratioprognostic factor

Identifiers

PMID36983614
PMCPMC10051294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.